JNJ logo
Johnson & Johnson
JNJ
151.33 (0.93%) 1.41
364.11(B)
Health Care
Pharmaceuticals
Johnson & Johnson together with its subsidiaries engages in the research and development manufacture and sale of various products in the healthcare field worldwide. It operates in two segments Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas such as immunology including rheumatoid arthritis psoriatic arthritis inflammatory bowel disease and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience consisting of mood disorders neurodegenerative disorders and schizophrenia; oncology such as prostate cancer hematologic malignancies lung cancer and bladder cancer; cardiovascular and metabolism including thrombosis diabetes and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers wholesalers distributors hospitals and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips knees trauma spine sports and other; surgery portfolios comprising advanced and general surgery technologies as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers hospitals and retailers as well as physicians nurses hospitals eye care professionals and clinics. The company was founded in 1886 and is based in New Brunswick New Jersey.
My Holdings:
(?% ownership)
Shares:
Cost basis:
Market cap:$364.11(B)
EV:$377.58(B)
Total Equity:$78.11(B)
Div. yield:3.28%
P/S:4.08
P/E:16.70
P/FCF:17.87
P/B:4.66
EPS:$9.1
FCF/share:$8.5
Dividend/share:$5.0
Book value/share:$32.5
ROIC:18.6%
ROA:11.9%
ROE:29.4%

JNJ Valuation

  Current Price
151.33
PE Valuation
N/A
Analyst targets
N/A
DCF
N/A
DCF (exit mult.)
N/A
Future P/E
N/A
Peter Lynch FV
N/A
Graham No.
N/A
DDM
N/A

Using the PEvaluation method, the intrinsic value estimate of JNJ is $153.4.
At the current price of 151.3, JNJ is 1% undervalued.

Based on 0 valuation methods, the average fair value estimate for JNJ is $N/A (NaN% overvalued).

Valuations range from $1.7976931348623157e+308 (N/A) to $0.0 (N/A).

PEvaluation

1% undervalued
Low
$115
Mid
$153
High
$192
Current price
$151
Fair P/E
Margin of safety
Shares outstan...ROICRevenue growthDebt/FCFAssets/Liabili...
Economic moat: Wide

Analyst Price Targets

10% undervalued
Low
$150
Mid
$167
High
$185
Current price
$151
Strong Buy4
Buy7
Hold13
Sell0
Strong Sell0

Estimated EPS

LowAvgHigh#
FY+110.510.610.723
FY+210.711.111.622
FY+310.511.813.316
FY+411.012.213.46
FY+512.113.214.76

Discounted Cash Flow

Forecast years
Terminal Growth Rate
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Discounted Cash Flow (exit mult.)

Forecast years
Exit FCF Multiple
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Future P/E Valuation

Projection Years
Base Revenue
Revenue Growth Rate
Final Net Margin
Final P/E Ratio
Discount Rate

Peter Lynch Fair Value

Earnings Per Share
Growth Rate (*)

(*) Growth rate is capped between 5 and 25

Graham Formula

Earnings Per Share
Expected Growth Rate
Government Bond Rate

Dividend Discount Model

Annual Dividend
First Stage Length (Years)
First Stage Growth Rate
Final Growth Rate
Discount Rate

(*) First stage rowth rate is capped to 20%

TTM Financials

Income (TTM)

RevenueGrossNet
Revenue$89.33(B)
Gross profit$61.55(B)
EBITDA$30.02(B)
Net income$21.81(B)
Gross margin68.9%
Operating margin24.7%
Net margin24.4%
Shares outstanding:2.41(B)

Balance sheet

Cash & ST inv.Other ST assetsLong term assetsCurrent liabilitiesLong term debtOther LT liabilitiesEquity
Total assets$193.67(B)
Current assets$71.55(B)
Total liabilities$115.56(B)
Current liabilities$56.90(B)
Cash & Short-term inv.$38.78(B)
Long-term debt$38.35(B)
Total intangibles$81.22(B)
PP&E$20.87(B)

Cash flow (TTM)

CFOCFICFF
FCF$20.37(B)
CapEx$-4.41(B)
Dividends paid$-11.94(B)
Stock issued$1.09(B)
Stock repurchased$-3.08(B)
Stock-based comp.$1.16(B)
Debt issued$34.59(B)
Debt repaid$-12.90(B)

Per share data

Price: $151
Revenue: $37.1 (4.1x | 24.5%) Gross profit: $25.6 (5.9x | 16.9%) Earnings: $9.06 (16.7x | 6.0%)
FCF: $8.47 (17.9x | 5.6%) Stock-based Comp.: $0.48 (313.3x | 0.3%) Dividend: $4.96 (30.5x | 3.3%)
Total Assets: $80.5 (1.9x | 53.2%) Total Liabilities: $48.0 (3.2x | 31.7%) Book Value: $32.5 (4.7x | 21.5%) Cash & ST inv.: $16.1 (9.4x | 10.7%) Debt: $15.9 (9.5x | 10.5%)

Growth Estimates

Revenue

CAGR: 4.1%
FY+1FY+2FY+3FY+4FY+5
FY+1$91.24(B)
FY+2(+4.1%)$94.98(B)
FY+3(+4.1%)$98.87(B)
FY+4(+3.4%)$102.21(B)
FY+5(+5.0%)$107.34(B)

Net Income

CAGR: 4.8%
FY+1FY+2FY+3FY+4FY+5
FY+1$25.65(B)
FY+2(+3.9%)$26.65(B)
FY+3(+6.6%)$28.42(B)
FY+4(+1.2%)$28.76(B)
FY+5(+7.5%)$30.91(B)

EPS

CAGR: 5.5%
FY+1FY+2FY+3FY+4FY+5
FY+1$10.61
FY+2(+4.5%)$11.09
FY+3(+6.5%)$11.81
FY+4(+3.0%)$12.17
FY+5(+8.1%)$13.16

FCF per share

CAGR: 1.0%
FY+1FY+2FY+3
FY+1$13.53
FY+2(-5.6%)$12.77
FY+3(+8.0%)$13.79

Historical Financials

Showing limited histrical data. Access 10+ years of financials now! Upgrade
YearlyQuarterly
Income
FY2005FY2006FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
FY2005FY2006FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024TTM5Y avg5Y CAGR
Revenue82.58(B)78.74(B)79.99(B)85.16(B)88.82(B)89.33(B)83.06(B)2%
COGS28.43(B)23.40(B)24.60(B)26.55(B)27.47(B)28.32(B)26.09(B)-1%
Gross Profit54.16(B)55.34(B)55.39(B)58.61(B)61.35(B)61.01(B)56.97(B)3%
Total OpEx.34.42(B)34.40(B)34.38(B)35.20(B)39.20(B)38.94(B)35.52(B)3%
  R&D12.34(B)14.28(B)14.13(B)15.09(B)17.23(B)16.91(B)14.61(B)9%
  SG&A22.08(B)20.12(B)20.25(B)20.11(B)21.97(B)22.02(B)20.91(B)-0%
Operating Income19.73(B)20.94(B)21.01(B)23.41(B)22.15(B)22.07(B)21.45(B)3%
Interest Expense-201.00(M)-183.00(M)-276.00(M)-772.00(M)-755.00(M)-804.00(M)-437.40(M)39%
Interest Income111.00(M)53.00(M)490.00(M)1.26(B)1.33(B)1.30(B)649.40(M)86%
Pre-tax income16.50(B)19.18(B)19.36(B)15.06(B)16.69(B)26.60(B)17.36(B)0%
Income tax-1.78(B)-1.38(B)-2.99(B)-1.74(B)-2.62(B)-4.79(B)-2.10(B)10%
Net Income14.71(B)20.88(B)17.94(B)35.15(B)14.07(B)21.81(B)20.55(B)-1%
Cash flow
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Stock-based Comp.FCFCFONet IncomeD&ACFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Total AssetsTotal LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
EPS (Basic)FCF/ShareDividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
P/EP/SEV/EarningsP/FCFP/BEV/FCFDebt/EquityPayout ratio
Margins
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Net Income MarginOperating MarginGross MarginEBITDA MarginFCF Margin
Returns
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
ROICROAROCEROE
Shares outstanding
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Shares (Basic)Shares (Diluted)
Market Cap.
FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Market Cap.

Similar Companies

Ownership

Major holders

Insiders: 0.06%
Institutions: 73.38%
Other: 26.57%

Institutional ownership

9.68% Vanguard Group Inc8.37% Blackrock Inc.5.59% State Street Corporati...2.40% Geode Capital Manageme...1.82% Morgan Stanley1.61% JPMORGAN CHASE & CO1.32% State Farm Mutual Auto...1.28% Northern Trust Corpora...1.26% NORGES BANK1.01% Wellington Management ...39.04% Others

Insider transactions

Show:
Buys
Sells
Grants
DateSharesTotal ($)Price ($)NameTitle
Grant2025-03-18130,85200.0DUATO JOAQUIN BOIXChief Executive Officer
Sell2025-02-256,9991,160,994165.9DECKER ROBERT JOfficer
Grant2025-02-256,999712,988101.9DECKER ROBERT JOfficer
Sell2025-02-1840362,928156.1SCHMID TIMOTHYOfficer
Sell2025-02-0713,0152,002,878153.9WOLK JOSEPH JChief Financial Officer
Grant2025-02-0732,7623,278,166100.1WENGEL KATHRYN EChief Operating Officer
Grant2025-02-0758,5045,853,910100.1TAUBERT JENNIFER LOfficer
Grant2025-02-0713,0151,302,281100.1WOLK JOSEPH JChief Financial Officer
Grant2025-02-07126,36912,644,482100.1DUATO JOAQUIN BOIXChief Executive Officer
Buy2024-12-121,000147,220147.2WEINBERGER MARK ADirector
Grant2024-10-1768,89000.0WOLK JOSEPH JChief Financial Officer
Sell2024-08-305,635930,113165.1DECKER ROBERT JOfficer
Grant2024-08-305,635563,838100.1DECKER ROBERT JOfficer

Tools

Dividend Income

Investment Amount
Dividend Yield
What is the Dividend Income Calculator?

The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.

How to Use This Calculator?

Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.

Required Investment

Dividend Yield
Desired Yearly Payout
Desired Quarterly Payout
Desired Monthly Payout
What is the Required Investment Calculator?

The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.

How to Use This Calculator?

Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.

Future Dividend Yield

Base Dividend
Current Price
Number of Years
Dividend Growth Rate
What is the Future Yield Calculator?

The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.

How to Use This Calculator?

Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.